Epoetin delta

DB11624ApprovedWithdrawnProtein Based Therapies

Epoetin Delta is an ingredient in the EMA-withdrawn product Dynepo.

Mechanism
Curator reviewed
Code names
HMR-4396

Resolves to

Compound
UNII474EI5756YCAS261356-80-3
Targets
P19235EPOR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
8Marketed productsAcross 1 country and 1 labeller
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Epoetin delta, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In